Canterbury DHB

Context

Cyclophosphamide + ATG Detailed Schedule

Adverse Effects

Adverse effects include: nausea and vomiting, diarrhoea, mucositis, haemorrhagic cystitis, reversible alopecia, sterility, cardiomyopathy, skin rash, fluid retention, hyponatraemia and facial discomfort.

Supportive Measures

In This Section

Cyclophosphamide

ATG/ALG Guidelines

About this Canterbury DHB document (12609):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 12609